Dr. John Leonard Discusses New Data from PYRAMID Study on Non-Germinal Center B-Cell-Like Subtype Diffuse Large Cell LymphomaPosted: December 17, 2015
In this video from the ASCO Post, Lymphoma Program Director, Dr. John Leonard discusses results presented at the 2015 meeting of the American Society of Hematology from the recently completed Pyramid trial. This multi-center phase II study sought to determine whether R-CHOP was more effective with or without bortezomib in patients with untreated non-germinal center B-cell-like subtype diffuse large cell lymphoma. (non-GCB DLBCL)
The study’s full abstract can be read here.